 |
Home | Contact Us | Site Map |
 |
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
 |
||
| Investors |
 |
| Senior Management |
|
| Board of Directors |
|
| Advisors |
|
| Collaborators |
|
Marinus has many distinguished advisors and collaborators who have partnered in developing ganaxolone for the treatment of epilepsy, posttraumatic stress disorder and fragile-X syndrome.
ClinicalJacqueline A. French, M.D. – Epilepsy Center, New York University
John Pellock, M.D. – Medical College of Virginia, Virginia Commonwealth University
Regulatory
Cynthia McCormick, M.D. – McCormick Consulting
Toxicology
Raymond Stoll, Ph.D.
Pharmacokinetics
Henry J. Pieniaszek, Jr., Ph.D. – HPP Consulting & Services, Inc.
